268 related articles for article (PubMed ID: 16506222)
21. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract][Full Text] [Related]
22. Allelic loss studies do not provide evidence for the "endometriosis-as-tumor" theory.
Prowse AH; Fakis G; Manek S; Churchman M; Edwards S; Rowan A; Koninckx P; Kennedy S; Tomlinson IP
Fertil Steril; 2005 Apr; 83 Suppl 1():1134-43. PubMed ID: 15831286
[TBL] [Abstract][Full Text] [Related]
23. [Genetic analysis of endometriosis and ovarian cancer].
Obata K; Hoshiai H
Nihon Rinsho; 2001 Jan; 59 Suppl 1():217-20. PubMed ID: 11235170
[No Abstract] [Full Text] [Related]
24. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
[TBL] [Abstract][Full Text] [Related]
25. Cancer Implications for Patients with Endometriosis.
Wilbur MA; Shih IM; Segars JH; Fader AN
Semin Reprod Med; 2017 Jan; 35(1):110-116. PubMed ID: 28049216
[TBL] [Abstract][Full Text] [Related]
26. Histologic transformation of benign endometriosis to early epithelial ovarian cancer.
Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA
Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
Amemiya S; Sekizawa A; Otsuka J; Tachikawa T; Saito H; Okai T
Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
[TBL] [Abstract][Full Text] [Related]
29. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG
Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923
[TBL] [Abstract][Full Text] [Related]
31. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
Canet B; Pons C; Espinosa I; Prat J
Hum Pathol; 2012 May; 43(5):720-5. PubMed ID: 21944080
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic defects in endometriosis.
Thomas EJ; Campbell IG
Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
[TBL] [Abstract][Full Text] [Related]
33. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
[TBL] [Abstract][Full Text] [Related]
34. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
[TBL] [Abstract][Full Text] [Related]
35. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
Jiang X; Morland SJ; Hitchcock A; Thomas EJ; Campbell IG
Cancer Res; 1998 Apr; 58(8):1707-12. PubMed ID: 9563487
[TBL] [Abstract][Full Text] [Related]
36. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
[TBL] [Abstract][Full Text] [Related]
37. MiR‑381 regulates cell motility, growth and colony formation through PIK3CA in endometriosis‑associated clear cell and endometrioid ovarian cancer.
Hsu CY; Hsieh TH; Er TK; Chen HS; Tsai CC; Tsai EM
Oncol Rep; 2018 Dec; 40(6):3734-3742. PubMed ID: 30542723
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis.
Kondi-Pafiti A; Papakonstantinou E; Iavazzo C; Grigoriadis C; Salakos N; Gregoriou O
Arch Gynecol Obstet; 2012 Feb; 285(2):479-83. PubMed ID: 21717140
[TBL] [Abstract][Full Text] [Related]
39. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
Xiao W; Awadallah A; Xin W
Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
[TBL] [Abstract][Full Text] [Related]
40. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway.
Yamamoto S; Tsuda H; Takano M; Hase K; Tamai S; Matsubara O
J Pathol; 2008 Sep; 216(1):103-10. PubMed ID: 18600856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
